Search

everythinglearnresearchcommunity

for

Search:↓

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

The Polish Medical Association in Chicago effectively supported the Polish community during COVID-19.

Polish medical degrees face more complex recognition in the USA than American degrees do in Poland.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Higher uric acid levels are linked to fewer urinary symptoms in healthy Korean men.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Low-penetration genes might help personalize colorectal cancer prevention.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Obesity is linked to more severe lower urinary tract symptoms.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

New standards were created to make chemotherapy safer and improve cancer care.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.